Novacyt Group Microgen Bioproducts™ SARS-CoV-2 IgG EIA

For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.

Additional Details:
Additional Details: Weight: 0.60000kg



Product Code. 17172119

 N/A
N/A

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.


Description and Specification

Specification

Calibration Standard ELISA calibration format - Pos/neg controls included with the kit
Certifications/Compliance CE IVD certified, DoC Documentation
Content And Storage 2°C to 8°C
Control Sets Both positive and negative controls
CE Marker Yes
Detectable Analytes SARS-CoV-2 IgG Antibodies (Nucleocapsid Protein)
Detection Method Enzyme-linked immunosorbent assay; chromatography/colour change
Format 96-well Plate
Sample Type Human Plasma or Human Serum
Sensitivity 100% - > 14 days post PCR confirmation
Type Antibody ELISA
Formulation Chemical compositions are found in Safety Data Sheets
For Use With (Application) ELISA
For Use With (Equipment) Manual OR Automated ELISA Systems & Plate Reader for Interpretation
Includes Positive control 1 x 3.5 mL, Negative control 1 x 3.5 mL, Wash buffer 2 x 12 5 mL, Sample buffer 2 x 125 mL, Conjugate 1 x 60 mL, Substrate solution 1 x 60 mL, Stop solution 1 x 60 mL
Material Polypropylene Plates
No. of Reactions 480
Organism Group Antibodies
Packaging Type Foil pouches and plastic bottles
Quantity 15/Pk.
Sample Size 5 μL of human plasma or human serum
Species Human
Specificity 0.994
Sterility Sterile
Target Organism Class Antibodies/Nucleocapsid protein
Test Time <1.5 hr.

  • The Microgen Bioproducts™ SARS-CoV-2 IgG EIA introduces a highly sensitive and specific assay for the qualitative detection of IgG antibodies based on the nucleocapsid protein, usually detected two weeks after initial infection
  • The test is intended for the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions
  • Each kit contains 480 reactions (5 x 96 well plates) and includes all additional reagents required to perform each test –alongside positive/negative controls. Sample types include human serum and plasma
  • Convenient 480 reaction format (5 x 96 well plates) including all plates and additional reagents to perform the assay
  • Compliant with The Medicines and Healthcare Product Regulatory Agency Ministry (MHRA) TPP
  • High Sensitivity and Specificity
  • Less than 1 hour 30 minutes incubation time
  • Functional with human plasma and serum samples
  • No cross-reactivity with common viral pathogens
  • Validated for manual application, however also suitable for high-throughput ELISA automation
  • Vital in the process of monitoring COVID-19 antibodies